SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.53 Cr | ₹0.58 Cr | ₹0.28 Cr | ₹0.33 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.53 Cr |
| Mar2024 | ₹0.58 Cr |
| Mar2020 | ₹0.28 Cr |
| Mar2019 | ₹0.33 Cr |
How is Deferred Tax Assets / Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.53 Cr | -8.46 | |
| Mar2024 | ₹0.58 Cr | 110.55 | |
| Mar2020 | ₹0.28 Cr | -17.17 | |
| Mar2019 | ₹0.33 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹630.0 Cr | 0.1% | 3.4% | -28.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,855.0 Cr | 2.4% | 7.1% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,550.0 Cr | -0.2% | 3.8% | 15.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,906.0 Cr | 1.8% | 10.9% | 48.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,632.0 Cr | 1% | 4% | 16.6% | Stock Analytics | |
| CIPLA | ₹107,427.0 Cr | 0.3% | -0.9% | -6% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | 0.1% |
3.4% |
-28.1% |
| SENSEX | -2.9% |
-8% |
5.3% |
You may also like the below Video Courses